Study of Abraxane and Carboplatin to Treat Small Cell Lung Cancer

NCT00454324 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

30

Enrollment

OTHER

Sponsor class

Stopped slow accrual

Conditions

Small Cell Lung Cancer

Interventions

DRUG: Carboplatin
DRUG: Abraxane

Sponsor

UNC Lineberger Comprehensive Cancer Center

Collaborators

[object Object]